We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Minimal Oxygen Supplementation Recommended for Most Inpatients

By HospiMedica International staff writers
Posted on 13 Nov 2018
A new guidance statement reports that supplemental oxygen is not always indicated for acutely ill patients, and may contribute to higher mortality.

An expert panel from McMaster University (Hamilton, ON, Canada), Stellenbosch University (SU, South Africa), University Hospitals of Geneva (Switzerland), and other institutions convened to evaluated a recent systematic review and meta-analysis of 25 randomized controlled trials in order to develop recommendations for supplemental oxygen therapy in critically ill patients, surgical patients with sepsis, hospitalized patients, or patients en-route to hospital in an ambulance. More...
Postoperative, obstetric, and pediatric patients were not included in the review.

The systematic review, which was published in The Lancet in April 2018, found that supplemental oxygen in inpatients with normal oxygen saturation increases mortality, and recommended that oxygen should be administered conservatively. The international panel of experts made several key recommendations, including maintaining peripheral oxygen saturation (SpO2) at or below 96% in patients on supplemental oxygen; in patients with acute myocardial infarction (MI) or stroke, oxygen should not be administered if the initial SpO2 is higher 92%. The guidance recommendations were published on October 24, 2018, in BMJ.

“It is a longstanding cultural norm to provide supplemental oxygen to sick patients, regardless of their blood oxygen saturation. A recent systematic review and meta-analysis has shown that too much supplemental oxygen increases mortality for medical patients in hospital,” concluded lead author Reed Siemieniuk, MD, PhD, of McMaster University, and colleagues. “A target SpO2 range of 90-94% seems reasonable for most patients, and 88-92% for patients at risk of hypercapnic respiratory failure seems wide enough to allow for normal fluctuation, and is likely low enough to avoid harm.”

The reasons as to why excessive supplemental oxygen increases mortality remain uncertain. Excessive oxygen can lead to reduced cardiac output, vasoconstriction, inflammation, and oxidative stress. In addition, excessive oxygen might lead to falsely reassuring SpO2 values and make it difficult to recognize when a patient’s condition worsens.

Related Links:
McMaster University
Stellenbosch University
University Hospitals of Geneva

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
Open Stapler
PROXIMATE Linear Cutter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.